drugset / Trial / NCT07044271
A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The main purpose of this study is to measure how much olomorasib gets into the bloodstream and how long it takes the body to get rid of it. Healthy participants will take olomorasib by mouth. The study will last about 7 weeks and will include 10 back-to-back overnight stays in the research center.
Timeline
- Start
- 2025-07-11
- Primary completion
- 2025-11-08
- Completion
- 2025-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olomorasib | Small molecule | — | Oral |
Indications
No indication recorded.